Tyra Biosciences to exchange 3M shares for pre-funded warrants with Boxer Capital, RA Capital

Tyra Biosciences, Inc.

Boxer Capital exchanges 2M shares, RA Capital exchanges 1M shares of common stock.
Each pre-funded warrant has $0.001 exercise price, immediate exercisability, no expiration.
Exchange expected to close on or before October 22, 2024.
Warrants include beneficial ownership limitations of 9.99% or 19.99% at holder's election.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.